The Potential of Stem Cells to Improve Stroke Treatment
Summary
- A pair of University of Miami Miller School of Medicine stroke experts are examining how stem cells interact with the immune system to protect and repair the brain after stroke.
- Dr. Dileep Yavagal and Dr. Nadia McMillan collaborated on a review that explores how stem cell–based therapies could transform recovery for millions of stroke survivors worldwide.
- The insights of Dr. Yavagal and Dr. McMillan pave the way for next-generation stroke therapies that could extend treatment windows and improve quality of life for patients with limited options.
A pair of University of Miami Miller School of Medicine stroke experts are examining how stem cells interact with the immune system to protect and repair the brain after stroke.
Dileep R. Yavagal, M.D., professor of neurology and neurosurgery at the University of Miami Miller School of Medicine, and Nadia McMillan, M.D., Ph.D., a neuroendovascular fellow in the Miller School’s Department of Neurological Surgery, collaborated on a review recently published in Nature Reviews Neuroscience that explores how stem cell–based therapies could transform recovery for millions of stroke survivors worldwide.
Stroke and Stem Cells
Stroke remains a leading cause of long-term disability, often causing paralysis and offering limited treatment options if the narrow window for treatment with clot-busting therapies is missed. The work of Dr. Yavagal, whose research focuses on intra-arterial delivery of stem cells to the brain to maximize therapeutic impact by targeting damaged tissue directly, and Dr. McMillan highlights how mesenchymal stem cells and neural stem cells interact with the immune system to reduce inflammation, restore blood–brain barrier integrity and stimulate neural circuit remodeling—all key steps toward functional stroke recovery.
“Stem cells provide a tremendous new avenue for recovery after stroke paralysis,” said Dr. Yavagal, a global leader in endovascular stroke therapy and regenerative neuroscience who has served on steering committees for landmark clinical trials, co-authored American Heart Association guidelines and led the first U.S. multicenter trial of intra-arterial stem cell therapy for stroke. “This review highlights advances showing how non-controversial stem cells such as mesenchymal stem cells and neural stem cells can decrease brain inflammation, enhance repair and lead to better outcomes.”
The crosstalk between stem cells and immune cells, the researchers noted, influence neuroinflammation, neural plasticity and circuit remodeling. Those determinants have a significant influence on stroke recovery. These stem cell–immune cell dynamics shape the effectiveness of stem cell therapies and offer the opportunity for targeted strategies to optimize immune modulation and enhance neuroprotection.
Extending Stroke Treatment Windows
While early clinical trials show promise, further research is needed to optimize delivery methods, understand mechanisms of immune modulation and ensure patient safety prior to widespread clinical use. The insights of Dr. Yavagal and Dr. McMillan pave the way for next-generation stroke therapies that could extend treatment windows and improve quality of life for patients with limited options.
“As someone who spent my Ph.D. studying neural stem cells, it’s incredibly meaningful to now care for patients with severe strokes and work to translate that science into real therapies,” said Dr. McMillan, a physician-scientist with expertise in neural stem cell biology and advanced stroke care. “By continuing research to understand the underlying mechanisms, we can finally see a clear path toward making stem cell–based neural repair a real option for stroke recovery.”
Tags: Department of Neurological Surgery, Department of Neurology, Dr. Dileep Yavagal, neurology, stem cell therapies, stem cells, stroke, stroke outcomes, thrombectomy